We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Breath Test Could Diagnose Colorectal Cancer

By LabMedica International staff writers
Posted on 19 Dec 2012
A simple breath analysis could be used for colorectal cancer screening, which should improve outcomes in gastrointestinal cancer patients.

Analysis of the volatile organic compounds (VOCs), which can be detected in the breath of cancer patients, is a new frontier in cancer screening as malignant tissues have different metabolism compared to normal healthy cells.

A team of scientist at the University Aldo Moro (Bari, Italy) collected exhaled breath from 37 patients with colorectal cancer and 41 healthy controls, which was processed offline to evaluate the VOC profile. More...
The VOCs of interest had been identified and selected, and VOC patterns were able to discriminate patients from controls.

Exhaled breath was collected in a Tedlar, inert bag (Sigma-Aldrich, St Gallen, Switzerland) from patients with colorectal cancer and healthy controls who were negative at colonoscopy, and processed by thermal‐desorber gas chromatography–mass spectrometry to evaluate the VOC profile. A probabilistic neural network (PNN) validated by the leave‐one‐out method was used to identify the pattern of VOCs that better discriminated between the two groups.

Some 37 patients and 41 controls were included in the trial phase. Application of a PNN to a pattern of 15 compounds showed a discriminant performance with a sensitivity of 86%, a specificity of 83%, and an accuracy of 85% calculated as the area under the receiver operating characteristic (ROC) curve .The accuracy of PNN analysis was confirmed in the validation phase on a further 25 subjects and the model correctly assigned 19 patients, giving an overall accuracy of 76%.

Levels of some specific VOCs such as 1,3-dimethylbenzene, 1,2-pentadiene, cyclohexane, methylcyclohexane and 4-methyloctane were higher in patients with colorectal cancer than in controls. The authors concluded that the pattern of VOCs in patients with colorectal cancer was different from that in healthy controls. The PNN in this study was able to discriminate patients with colorectal cancer with an accuracy of over 75 %. Exhaled breath VOC analysis appears to have potential clinical application in colorectal cancer screening, although further studies are required to confirm its reliability in heterogeneous clinical settings.

Donato F. Altomare, MD, the senior author said, “The technique of breath sampling is very easy and noninvasive, although the method is still in the early phase of development. Our study's findings provide further support for the value of breath testing as a screening tool." The study was published on December 5, 2012, in the journal British Journal of Surgery (BJS).

Related Links:

University Aldo Moro
Sigma-Aldrich



New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Collection and Transport System
PurSafe Plus®
Rapid Molecular Testing Device
FlashDetect Flash10
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researchers have developed two rapid blood tests for early Alzheimer’s detection (Photo courtesy of UConn)

Fast Low-Cost Alzheimer’s Tests Could Detect Disease in Early and Silent Stages

Early diagnosis remains one of the greatest challenges in combating Alzheimer’s disease, the most common cause of age-related dementia. With symptoms like memory loss and confusion typically appearing... Read more

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Microbiology

view channel
Image: EBP and EBP plus have received FDA 510(k) clearance and CE-IVDR Certification for use on the BD COR system (Photo courtesy of BD)

High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample

Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.